Signal Implanted interfaces enter broader clinical trials

Summary

This signal concerns implanted brain-computer interfaces moving into larger clinical trials. Companies such as Neuralink, Synchron and Neuracle are expanding their human trials. Their stated aim is to develop a tangible product rather than remain at the research stage. Sitra cites an MIT Technology Review article from April 2025 describing the critical test these devices now face. The development suggests direct links between the brain and machines are edging toward commercial reality. Sitra uses it as one of the signals behind an imagined future article on everyday neurotechnology and tightening regulation.